ERβ binds N-CoR in the presence of estrogens via an LXXLL-like motif in the N-CoR C-terminus

Nuclear Receptor

Volumn 1, Issue , 2003, Pages

  Webb, Paul ^a   Valentine, Cathleen ^a,b   Nguyen, Phuong ^a   Price Jr , Richard H ^a,b   Marimuthu, Adhirai ^a   West, Brian L ^a   Baxter, John D ^a   Kushner, Peter J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CELL NUCLEUS RECEPTOR; COUMESTROL; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR BETA; FACTOR AF2; FULVESTRANT; GENISTEIN; HISTONE DEACETYLASE; ISOPROTEIN; LEUCINE; LIGAND; NUCLEAR RECEPTOR COACTIVATOR 2; PHYTOESTROGEN; RALOXIFENE; RECEPTOR BLOCKING AGENT; REPRESSOR PROTEIN; RETINOIC ACID; SILENCING MEDIATOR OF RETINOID AND THYROID RESPONSIVE TRANSCRIPTION FACTOR; TAMOXIFEN; THYROID HORMONE; TRANSCRIPTION FACTOR; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MOLECULAR RECOGNITION; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RECEPTOR BINDING; RECEPTOR SENSITIVITY;

EID: 2442635964     PISSN: 14781336     EISSN: None     Source Type: Journal    
DOI: 10.1186/1478-1336-1-4     Document Type: Article

References (53)

1. Ribeiro RCJ, Kushner PJ, Baxter JD: The nuclear hormone receptor gene superfamily. Annu Rev Med 1995, 46:443-453.
2. Weatherman RV, Fletterick RJ, Scanlan TS: Nuclear-receptor ligands and ligand-binding domains. Annu Rev Biochem 1999, 68:559-581.
3. McKenna NJ, O'Malley BW: Nuclear receptors, coregulators, ligands, and selective receptor modulators: making sense of the patchwork quilt. Ann N Y Acad Sci 2001, 949:3-5.
4. Glass CK, Rosenfeld MG: The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 2000, 14:121-141.
5. Glass CK, Rose DW, Rosenfeld MG: Nuclear receptor coactivators. Curr Opin Cell Biol 1997, 9:222-232.
6. Chen D, Ma H, Hong H, Koh SS, Huang SM, Schurter BT, Aswad DW, Stallcup MR: Regulation of transcription by a protein methyltransferase. Science 1999, 284:2174-2177.
7. Ito M, Yuan CX, Okano HJ, Darnell RB, Roeder RG: Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action. Mol Cell 2000, 5:683-693.
8. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM: A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92:829-839.
9. Knutti D, Kralli A: PGC-1, a versatile coactivator. Trends Endocrinol Metab 2001, 12:360-365.
10. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG: Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. Embo J 1995, 14:3741-3751.
11. Moraitis AN, Giguere V, Thompson CC: Novel mechanism of nuclear receptor corepressor interaction dictated by activation function 2 helix determinants. Mol Cell Biol 2002, 22:6831-6841.
12. Seol W, Choi HS, Moore DD: An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 1996, 272:1336-1339.
13. Zhang H, Thomsen JS, Johansson L, Gustafsson JA, Treuter E: DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors. J Biol Chem 2000, 275:39855-39859.
14. Montano MM, Ekena K, Delage-Mourroux R, Chang W, Martini P, Katzenellenbogen BS: An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. Proc Natl Acad Sci U S A 1999, 96:6947-6952.
15. Oesterreich S, Zhang Q, Hopp T, Fuqua SA, Michaelis M, Zhao HH, Davie JR, Osborne CK, Lee AV: Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation. Mol Endocrinol 2000, 14:369-381.
16. Webb P, Anderson CM, Valentine C, Nguyen P, Marimuthu A, West BL, Baxter JD, Kushner PJ: The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol Endocrinol 2000, 14:1976-1985.
17. Marimuthu A, Feng W, Tagami T, Nguyen H, Jameson JL, Fletterick RJ, Baxter JD, West BL: TR surfaces and conformations required to bind nuclear receptor corepressor. Mol Endocrinol 2002, 16:271-286.
18. Feng W, Ribeiro RC, Wagner RL, Nguyen H, Apriletti JW, Fletterick RJ, Baxter JD, Kushner PJ, West BL: Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 1998, 280:1747-1749.
19. Heery DM, Kalkhoven E, Hoare S, Parker MG: A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997, 387:733-736.
20. Parker MG: Transcriptional activation by oestrogen receptors. Biochem Soc Symp 1998, 63:45-50.
21. Katzenellenbogen BS, Montano MM, Ediger TR, Sun J, Ekena K, Lazennec G, Martini PG, McInerney EM, Delage-Mourroux R, Weis K, Katzenellenbogen JA: Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res 2000, 55:163-193.
22. Couse JE, Mahato D, Eddy EM, Korach KS: Molecular mechanism of estrogen action in the male: insights from the estrogen receptor null mice. Reprod Fertil Dev 2001, 13:211-219.
23. Pettersson K, Gustafsson JA: Role of estrogen receptor beta in estrogen action. Annu Rev Physiol 2001, 63:165-192.
24. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
25. Hall JM, McDonnell DP: The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999, 140:5566-5578.
26. Pettersson K, Delaunay F, Gustafsson JA: Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene 2000, 19:4970-4978.
27. An J, Ribeiro RC, Webb P, Gustafsson JA, Kushner PJ, Baxter JD, Leitman DC: Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc Natl Acad Sci U S A 1999, 96:15161-15166.
28. Webb P, Lopez GN, Uht RM, Kushner PJ: Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 1995, 9:443-456.
29. Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price Jr RH, Pestell RG, Kushner PJ: Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J Biol Chem 2002, 277:24353-24360.
30. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS: Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997, 277:1508-1510.
31. Webb P, Nguyen P, Valentine C, Lopez GN, Kwok GR, McInerney E, Katzenellenbogen BS, Enmark E, Gustafsson JA, Nilsson S, Kushner PJ: The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol 1999, 13:1672-1685.
32. Weatherman RV, Scanlan TS: Unique protein determinants of the subtype-selective ligand responses of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites. J Biol Chem 2001, 276:3827-3832.
33. Tremblay GB, Tremblay A, Labrie F, Giguere V: Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex. Mol Cell Biol 1999, 19:1919-1927.
34. McDonnell DP, Chang CY, Norris JD: Development of peptide antagonists that target estrogen receptor-cofactor interactions. J Steroid Biochem Mol Biol 2000, 74:327-335.
35. Norris JD, Chang C, McDonnell DP: Estrogen receptor-cofactor interactions as targets for novel drug discovery. Ernst Schering Res Found Workshop 2001, 181-201.
36. Tremblay GB, Giguere V: Coregulators of estrogen receptor action. Crit Rev Eukaryot Gene Expr 2002, 12:1-22.
37. Seol W, Hanstein B, Brown M, Moore DD: Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner). Mol Endocrinol 1998, 12:1551-1557.
38. Kressler D, Schreiber SN, Knutti D, Kralli A: The PGC-1-related protein PERC is a selective coactivator of estrogen receptor alpha. J Biol Chem 2002, 277:13918-13925.
39. Webb P, Nguyen P, Kushner PJ: Differential SERM effects on corepressor binding dictate ER alpha activity in vivo. J Biol Chem 2002.
40. Ding XF, Anderson CM, Ma H, Hong H, Uht RM, Kushner PJ, Stallcup MR: Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol Endocrinol 1998, 12:302-313.
41. Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick RJ, Yamamoto KR: Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev 1998, 12:3343-3356.
42. Zhang J, Hu X, Lazar MA: A novel role for helix 12 of retinoid X receptor in regulating repression. Mol Cell Biol 1999, 19:6448-6457.
43. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M: Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997, 389:753-758.
44. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL: The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998, 95:927-937.
45. Chang C, Norris JD, Gron H, Paige LA, Hamilton PT, Kenan DJ, Fowlkes D, McDonnell DP: Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta. Mol Cell Biol 1999, 19:8226-8239.
46. Norris JD, Paige LA, Christensen DJ, Chang CY, Huacani MR, Fan D, Hamilton PT, Fowlkes DM, McDonnell DP: Peptide antagonists of the human estrogen receptor. Science 1999, 285:744-746.
47. Paige LA, Christensen DJ, Gron H, Norris JD, Gottlin EB, Padilla KM, Chang CY, Ballas LM, Hamilton PT, McDonnell DP, Fowlkes DM: Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. Proc Natl Acad Sci U S A 1999, 96:3999-4004.
48. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustafsson JA, Carlquist M: Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. Embo J 1999, 18:4608-4618.
49. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M: Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000, 103:843-852.
50. Norris JD, Fan D, Sherk A, McDonnell DP: A negative coregulator for the human ER. Mol Endocrinol 2002, 16:459-468.
51. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, Webb P: Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 2000, 74:311-317.
52. Ordentlich P, Downes M, Xie W, Genin A, Spinner NB, Evans RM: Unique forms of human and mouse nuclear receptor corepressor SMRT. Proc Natl Acad Sci U S A 1999, 96:2639-2644.
53. Webb P, Nguyen P, Shinsako J, Anderson C, Feng W, Nguyen MP, Chen D, Huang SM, Subramanian S, McKinerney E, Katzenellenbogen BS, Stallcup MR, Kushner PJ: Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol Endocrinol 1998, 12:1605-1618.